Co-opting Innate and Adaptive Immunity against Cancer

Researchers at the Massachusetts Institute of Technology in Cambridge have devised a way to completely eradicate large, established tumors in mice. Their four-component strategy comprises a tumor-specific antibody and vaccine, along with IL2 and anti-PD-1 therapy, which employs both innate and adaptive immunity for tumor destruction.